Best practice in primary care pathology: review 5
- 1Department of Chemical Pathology, Bishop Auckland General Hospital, Durham, UK
- 2Sowerby Centre for Health Informatics, Bede House, All Saints Business Centre, Newcastle upon Tyne, UK
- 3Department of Gastroenterology, Queen’s Medical Centre, Nottingham, UK
- 4Department of Haematology, City Hospitals Sunderland NHS Trust, Sunderland Royal Hospital, Sunderland, UK
- 5Department of Haematology, James Cook University Hospital, Teesside, UK
- 6Department of Clinical Biochemistry, University Hospital Aintree Liverpool, UK
- Correspondence to: W S A Smellie Department of Chemical Pathology, Bishop Auckland General Hospital, Cockton Hill Road, Bishop Auckland, County Durham DL14 6AD, UK;info{at}smellie.com
- Accepted 20 February 2006
- Published Online First 27 April 2006
Abstract
This fifth best practice review examines three series of common primary care questions in laboratory medicine: (1) minor liver function test abnormalities; (2) laboratory monitoring of patients receiving lithium; and (3) investigation of possible venous thromboembolism. The review is presented in question–answer format, referenced for each question series. The recommendations represent a precis of guidance found using a standardised literature search of national and international guidance notes, consensus statements, health policy documents and evidence-based medicine reviews, supplemented by Medline Embase searches to identify relevant primary research documents. They are not standards but form a guide to be set in the clinical context. Most are consensus-based rather than evidence-based. They will be updated periodically to take account of new information.
- ALP, alkaline phosphatase
- ALT, alanine aminotransferase
- AST, aspartate transaminase
- BNF, British National Formulary
- DVT, deep venous thrombosis
- GGT, γ-glutamyl transpeptidase
- GMS, General Medical Services
- NAFLD, non-alcoholic fatty liver disease
- ULN, upper limit of normal
Footnotes
-
Published Online First 19 May 2006
-
Competing interests: None declared.









